Form 8-K - Current report:
SEC Accession No. 0001193125-23-265256
Filing Date
2023-10-27
Accepted
2023-10-27 17:15:04
Documents
14
Period of Report
2023-10-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d563263d8k.htm   iXBRL 8-K 30291
2 EX-3.1 d563263dex31.htm EX-3.1 183358
  Complete submission text file 0001193125-23-265256.txt   414544

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dna-20231027.xsd EX-101.SCH 3893
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dna-20231027_def.xml EX-101.DEF 14039
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dna-20231027_lab.xml EX-101.LAB 23296
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dna-20231027_pre.xml EX-101.PRE 15071
8 EXTRACTED XBRL INSTANCE DOCUMENT d563263d8k_htm.xml XML 5505
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 231356360
SIC: 2836 Biological Products, (No Diagnostic Substances)